Amneal Pharmaceuticals Inc (AMRX) stock has gained 1.75% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With AMRX Stock Today?
Amneal Pharmaceuticals Inc (AMRX) stock is trading at $5.24 as of 11:57 AM on Friday, Oct 23, a loss of -$0.19, or -3.41% from the previous closing price of $5.43. The stock has traded between $5.19 and $5.51 so far today. Volume today is less active than usual. So far 428,660 shares have traded compared to average volume of 1,090,442 shares.
To screen for more stocks like Amneal Pharmaceuticals Inc click here.
More About Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products and Specialty products. Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. It generates a majority of its revenue from the Generic business segment.
Click Here to get the full Stock Score Report on Amneal Pharmaceuticals Inc (AMRX) Stock.
